Financial News

My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

51.98 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
A Glimpse Into The Expert Outlook On Lantheus Holdings Through 6 Analysts
 
Via Benzinga
Q2 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including Lantheus... 
Via StockStory
Topics Artificial Intelligence
ResMed, Insulet, Lantheus, Inspire Medical Systems, and Evolent Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading. 
Via StockStory
Topics Economy
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) Screened as a Top Undervalued Stock with Strong Fundamentals
Lantheus Holdings (LNTH) is a value stock with a low P/E ratio, strong financial health, and high profitability, making it an attractive opportunity for value investors. 
Via Chartmill
Earnings Scheduled For August 6, 2025
 
Via Benzinga
What Does the Market Think About Lantheus Holdings?
 
Via Benzinga
Why Lantheus (LNTH) Stock Is Falling Today
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 3.1% on continued negative momentum after a downgrade by Truist Securities, which cited concerns over competitive pressures... 
Via StockStory
Topics Artificial Intelligence
Why Lantheus (LNTH) Stock Is Falling Today
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 4.7% in the afternoon session after Truist Securities downgraded the stock from a "Buy" to a "Hold" rating and slashed its... 
Via StockStory
This Union Pacific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings... 
Via Benzinga
4 Analysts Assess Lantheus Holdings: What You Need To Know
 
Via Benzinga
LNTH Q2 Deep Dive: Competitive Pressures and Guidance Cut Reshape Lantheus Outlook
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 4.1% year on year to $378 million. The company’s full-year revenue... 
Via StockStory
Lantheus (LNTH) Q2 Revenue Falls 4%
Via The Motley Fool
What's going on in today's session
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
Nasdaq Surges 1%; Uber Sales Top Estimates
 
Via Benzinga
Why Lantheus (LNTH) Stock Is Falling Today
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 29.8% in the afternoon session after the company reported disappointing second-quarter financial results and slashed its... 
Via StockStory
Topics Lawsuit
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Here are the top movers in Wednesday's session.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
The market is filled with gapping stocks in Wednesday's session.
Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
US Stocks Edge Higher; McDonald's Posts Upbeat Earnings
 
Via Benzinga
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) Shares Plunge 20.8% After Q2 2025 Earnings Miss and Weak Guidance
Lantheus Holdings (LNTH) Q2 2025 earnings miss estimates, revenue down 4.1%. Shares drop 20.8% as weak guidance raises concerns. FDA accepts NDA for PYLARIFY upgrade. 
Via Chartmill
Topics Earnings
Discover the top movers in Wednesday's pre-market session.
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops 20.8%
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 4.1% year on year to $378 million. The company’s full-year... 
Via StockStory
Lantheus (LNTH) Reports Q2: Everything You Need To Know Ahead Of Earnings
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings this Wednesday before market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence Government World Trade
LANTHEUS HOLDINGS INC (NASDAQ:LNTH): A Prime Value Investment with Strong Fundamentals
Lantheus Holdings (LNTH) is a standout value stock with strong financials, low P/E ratios, and high profitability, making it an attractive pick for value investors. 
Via Chartmill
Moderna, Lantheus, Centene, AMN Healthcare Services, and NeoGenomics Shares Plummet, What You Need To Know
A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the sector. Weakness in managed care providers was a significant factor, with companies like... 
Via StockStory
Topics Lawsuit World Trade
Why Is Lantheus Stock Trading Lower On Wednesday?
CMS proposes a $140 drug packaging threshold and a $655 diagnostic radiopharmaceutical threshold for CY 2026, using inflation-adjusted PPI data. 
Via Benzinga
Why Lantheus (LNTH) Stock Is Down Today
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 7.7% in the morning session after the stock hit a new 52-week low amid persistent investor concerns over rising competition... 
Via StockStory
Topics ETFs Stocks World Trade
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) – An Undervalued Stock with Strong Fundamentals
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is an undervalued healthcare stock with strong profitability, financial health, and reasonable growth potential, making it a candidate for value investors. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback